US Patent Issued to Enveric Biosciences Canada on Dec. 9 for "Substituted ethylamine fused heterocyclic mescaline derivatives" (Canadian Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,179, issued on Dec. 9, was assigned to Enveric Biosciences Canada Inc. (Calgary, Canada).

"Substituted ethylamine fused heterocyclic mescaline derivatives" was invented by Kaveh Matinkhoo (Calgary, Canada), David James Press (Calgary, Canada), Jessica Bik-jing Lee (Calgary, Canada), Ye Cai (Edmonton, Canada), Jillian M. Hagel (Calgary, Canada) and Peter J. Facchini (Calgary, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are novel fused mescaline derivative compounds, notably substituted ethylamine fused heterocyclic mescaline derivatives, including substituted ethylamine fused dioxolane mescaline derivatives, and pharmaceutical and ...